Neuroscience

Untangling the threads of early onset dementia

Changes in personality, behavior and language are hallmarks of frontotemporal dementia (FTD), the most common form of dementia in patients under the age of 65, which is associated with degeneration of the frontal and temporal ...

Medications

New drug may slow rapid progression of Parkinson's disease

Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...

Diseases, Conditions, Syndromes

Researchers unveil faster and more accurate COVID test

With new cases, hospitalizations and mortality rates holding steady in many parts of the world, University of Georgia researchers have developed a faster detection technique for COVID-19.

Medications

Researchers race to develop Paxlovid replacement

Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.

Alzheimer's disease & dementia

A new diagnostic model offers hope for Alzheimer's

A new mathematical model offers hope for better prediction and treatment of Alzheimer's disease. Most mathematical models of Alzheimer's are theoretical, focusing on short term molecular and cellular-level changes that cannot ...

page 1 from 2